Antibiotic Treatment in Patients Hospitalized for Nonsevere COVID-19
In this large cohort study of patients hospitalized with nonsevere COVID-19, there was no clinically meaningful difference in outcomes with early antibiotic treatment. Given the risks associated with unnecessary antibiotic treatment, these results argue against routine antibiotic use in this population.
Authors
- M. Pamela Griffin (ORCID: https://orcid.org/0009-0006-8016-5471)
- Rebecca J. Schwei (ORCID: https://orcid.org/0000-0002-6208-5703)
- Peter K. Lindenauer (ORCID: https://orcid.org/0000-0002-8414-0507)
- Penelope S. Pekow (ORCID: https://orcid.org/0000-0002-0180-1710)
- Michael S. Pulia (ORCID: https://orcid.org/0000-0001-5809-4060)
- Lucas Schulz (ORCID: https://orcid.org/0000-0001-6587-5439)
- Aurora Pop‐Vicas (ORCID: https://orcid.org/0000-0001-6702-3328)
- Valerie M. Vaughn (ORCID: https://orcid.org/0000-0003-4362-7842)
- Meng‐Shiou Shieh (ORCID: https://orcid.org/0000-0002-0063-7576)
Institutions
- University of Wisconsin–Madison (US)
- University of Massachusetts Chan Medical School (US)
- University of Utah (US)
- Baystate Health (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.11499
- Citations
- 3
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 3.79
Funders
- National Institutes of Health
- Agency for Healthcare Research and Quality